Plain-English translation of NCT06937099 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn's Disease research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing , a newer medication for Crohn's disease, either alone or combined with (a medication that can help with weight management). The trial wants to see if using both medications together works better than using by itself for people whose Crohn's disease is not well controlled and who are also overweight or have obesity.
Many people with moderate-to-severe Crohn's disease also struggle with weight-related health problems. This trial is investigating whether treating both conditions at the same time with these two medications could help more effectively than treating just the bowel disease alone.
You likely qualify if…
You likely don't qualify if…
You would participate for up to 61 weeks (about 14 months). You would receive one medication by intravenous infusion (IV, through a needle in your vein), then switch to receiving it as injections under your skin. Depending on which group you're randomly assigned to, you would also receive either the second medication or a placebo (inactive substance) as regular injections. You would have multiple visits to the clinic for infusions, injections, blood tests, and intestinal imaging to monitor how well the treatment is working and check for any side effects.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States